Article
A novel mutation (Cys145-->Stop) in Bruton's tyrosine kinase is associated with newly diagnosed X-linked agammaglobulinemia in a 51-year-old male.
Molecular medicine (Cambridge, Mass.) - 1 Sept 1996
Kornfeld S J, Haire R N, Strong S J, Tang H, Sung S S, Fu S M, Litman G W
Abstract excerpt
BACKGROUND: X-linked agammaglobulinemia (XLA) is a severe, life-threatening disease characterized by failure of B cell differentiation and antibody production and is associated with mutations in Bruton's tyrosine kinase (Btk). The proband in this study is a 51-year-old male presenting with chronic nasal congestion, recurrent sinusitis, sporadic pneumonia, and pronounced B cell deficiency. A family history...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
